Skip to content

    Neonatal and pediatric focused drug information

    Micromedex NeoFax and Pediatrics

    Trusted guidance for treating your youngest patients
    IMG-Micromedex-Email-62-1008x756

    Neonatal and pediatric patient care

    Clinical decision support tailored to patient population, age and indication

    Having access to distinct, population-specific drug information is critical to ensuring the safety of your most vulnerable patients, especially in fast-paced workflows in healthcare settings.

     

    Micromedex NeoFax® and Pediatrics solutions highlight variations in dosage, administration, pharmacokinetics, monitoring, and potential side effects, which can be different and clinically important across these populations. It offers a clear reference point for treatment options covering medication management, clinical studies, and guideline summaries.

    highlights

    Micromedex NeoFax and Pediatric drug information

    Building on the history and reputation of NeoFax, Micromedex neonatal and pediatrics content provides clinicians with trusted, evidence-based drug information for neonatal and pediatric patient care. The information is based on the same comprehensive editorial process behind Micromedex solutions, ensuring healthcare providers can rely on accurate data, guided by published literature, clinical guidelines, and regulatory information.
    ICO-lightning

    Ensure focus and save time

    Workflow efficiency for clincians:
    • Separate neonatal and pediatric monographs get you to the relevant population-specific information faster
    • Easy comparison of multiple products including infant formulas and human milk fortifiers to help you tailor enteral nutrition support to meet the needs of each patient

    ICO-heart

    Support patient safety

    Accurate clinical decision support:
    • Population-specific dosing based on indication and patient age, to help reduce errors for your smallest patients
    • Information that provides context, relevance, and caveats around available supporting evidence to inform off-label treatment decisions
    • The NeoFax and Pediatrics dosing calculators provide greater clinical accuracy and reliability in drug dosing

     

    ICO-device-mobile

    Access anywhere

    Drug reference content where and when you need it:

    • Full drug monograph and infant formula content is available online and on the new, consolidated mobile app
    Pills-V1_MDX_transparent

    “As far as my go-to source for pediatrics and neonatal, Micromedex is my number one. That’s what I rely on and that is what the neonatologists rely on. When there’s something special that the neonatologists want, compounding for a baby, Micromedex is right on top as far as getting you what to use, how much to use, what solution to use, and what the concentration is going to be.”

    Anthony Bono, Pharmacist, Englewood Hospital, New Jersey, United States

      Neofax CefTRIAXone-2-1

      NEOFAX IN ACTION

      Neonatal drug therapy differs significantly...

      Managing drug therapy of cefTRIAXone for a premature neonatal baby in the neonatal intensive care unit (NICU) is not the same as managing a six year old child in the pediatric intensive care unit (PICU).

      Peds CefTRIAXone-2-1

      PEDIATRICS IN ACTION

      ...from pediatric drug therapy

      There are clinically significant differences in all aspects of drug therapy for neonatal and pediatric populations: dose, uses, administration, monitoring, adverse effects and more. Providing distinct, focused drug information for these vulnerable populations is imperative so that clinicians have a clear point of reference for their specific patient.

      Ready to talk?

      Connect with a clinical decision support expert.

      Walking - desktop